| Dec'19 | Dec'18 | Dec'17 | ||||
|---|---|---|---|---|---|---|
Revenues: | ||||||
Total Revenues | ||||||
31 | 186 | 422 | ||||
Cost of revenues | ||||||
- | - | 419 | ||||
Gross Profit | ||||||
- | - | 2 | ||||
Selling, general and administrative expenses | ||||||
4,911 | 6,482 | 5,455 | ||||
Research and development expenses | ||||||
2,206 | 1,238 | 649 | ||||
Loss on impairment of intangible asset | ||||||
588 | 319 | - | ||||
Loss from Operations | ||||||
-7,675 | -7,854 | -6,103 | ||||
Other (Income) Expense: | ||||||
Amortization of debt discount | ||||||
- | 6,562 | 1,710 | ||||
Gain on extinguishment of convertible notes payable | ||||||
- | 1,481 | 257 | ||||
Interest (income) expense, net | ||||||
-49 | 298 | - | ||||
Interest expense, net | ||||||
- | - | 209 | ||||
Change in fair value of derivative liabilities | ||||||
- | 191 | -26 | ||||
Total Other (Income) Expense | ||||||
-49 | 5,187 | 1,688 | ||||
Net Loss | ||||||
-7,625 | -13,042 | -7,791 | ||||
Deemed dividend to preferred stockholders | ||||||
- | 3,310 | 459 | ||||
Net Loss Attributable to Common Stockholders | ||||||
-7,625 | -16,352 | -8,251 | ||||
Net Loss Per Basic and Diluted Common Share: | ||||||
-0.48 | -1.75 | -1.35 | ||||
Weighted Average Number of Common Shares Outstanding: Basic and Diluted | ||||||
15,760 | 9,362 | 6,126 | ||||
Product Sales [Member] | ||||||
Total Revenues | ||||||
- | - | 184 | ||||
Royalty Income [Member] | ||||||
Total Revenues | ||||||
31 | 116 | 137 | ||||
Contract Research - Related Party [Member] | ||||||
Total Revenues | ||||||
- | 70 | - | ||||
Total Revenues | ||||||
- | - | 99 | ||||